ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2020

Go back to ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2020

ResMed (RMD) Tops Q1 EPS by 6c, Revenues Beat

October 24, 2019 4:09 PM EDT

ResMed (NYSE: RMD) reported Q1 EPS of $0.93, $0.06 better than the analyst estimate of $0.87. Revenue for the quarter came in at $681.1 million versus the consensus estimate of $660.66 million.

First Quarter 2020 Highlights

Revenue increased 16% to $681.1 million; up 17% on a constant currency basisGross margin expanded 120 bps... More